V029-2910 Screening compound: 4-[4-(2-fluorophenoxy)-6-{[4-(trifluoromethyl)phenyl]methyl}-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

V029-2910 Screening compound: 4-[4-(2-fluorophenoxy)-6-{[4-(trifluoromethyl)phenyl]methyl}-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine
V029-2910 Screening compound: 4-[4-(2-fluorophenoxy)-6-{[4-(trifluoromethyl)phenyl]methyl}-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-2910
4-[4-(2-fluorophenoxy)-6-{[4-(trifluoromethyl)phenyl]methyl}-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-2910

Molecular Formula

C25H24F4N4O2 (C25 H24 F4 N4 O2)

Compound Name

4-[4-(2-fluorophenoxy)-6-{[4-(trifluoromethyl)phenyl]methyl}-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

IUPAC name

4-[4-(2-fluorophenoxy)-6-{[4-(trifluoromethyl)phenyl]methyl}-5H6H7H8H-pyrido[43-d]pyrimidin-2-yl]morpholine

SMILES

FC(c1ccc(CN(CC2)Cc3c2nc(N2CCOCC2)nc3Oc(cccc2)c2F)cc1)(F)F

InChI

InChI=1S/C25H24F4N4O2/c26-20-3-1-2-4-22(20)35-23-19-16-32(15-17-5-7-18(8-6-17)25(27,28)29)10-9-21(19)30-24(31-23)33-11-13-34-14-12-33/h1-8H,9-16H2

InChI Key

BLGBWHFSXWGASX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19932658

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

488.48

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.310

Distribution Coefficient, logD

5.304

Water Solubility, LogSw

-5.87

Polar Surface Area

41.585

Acid Dissociation Constant (pKa)

20.40

Base Dissociation Constant (pKb)

5.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

V029-2910 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

BRD4 Targeted Library (4534 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Others
  • Kinases

References: we are preparing a list of scientific research reports with V029-2910 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-2910?
Check Price and Availability of V029-2910, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-2910 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-2910
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-2910
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-2910 available by request